The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Objective measures of physical fatigue in women undergoing adjuvant therapy for early-stage breast cancer.
S. Waliany
No relevant relationships to disclose
C. Dieli-Conwright
No relevant relationships to disclose
A. Hurria
Consultant or Advisory Role - Amgen; Genentech
Research Funding - Abraxis BioScience; Pfizer
S. Patel
No relevant relationships to disclose
P. H. Frankel
Research Funding - Cephalon
T. H. Luu
Research Funding - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Onyx; Pfizer
J. Chao
No relevant relationships to disclose
J. E. Mortimer
Research Funding - Cephalon